Global Precision Medical Imaging Market: Propelling due to Growing Research and Development - PMI
20 juil. 2020 10h50 HE
|
PMI
Covina, CA, July 20, 2020 (GLOBE NEWSWIRE) -- The report "Global Precision Medical Imaging Market, By Application (Cardiovascular, Neurology, Gastroenterology, Infectious Diseases, Oncology, and...
RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services
10 juin 2020 08h36 HE
|
RenovaCare, Inc.
ROSELAND, N.J., June 10, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics
05 févr. 2020 07h30 HE
|
Vineti
A coalition of strategic industry leaders – including Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company (Gilead Sciences, Inc.) – joins the company’s existing investor syndicate to...
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
25 sept. 2019 11h20 HE
|
Schall Law
LOS ANGELES, Sept. 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novartis AG...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
18 sept. 2019 11h40 HE
|
Schall Law
LOS ANGELES, Sept. 18, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novartis AG...
Glancy Prongay & Murray LLP Continues its Investigation on Behalf of Novartis AG Investors (NVS)
11 sept. 2019 16h30 HE
|
Glancy Prongay & Murray LLP
LOS ANGELES, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) continues its investigation on behalf of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS) investors...
INVESTOR ALERT: Law Offices of Howard G. Smith Continues its Investigation on Behalf of Novartis AG Investors (NVS)
11 sept. 2019 13h44 HE
|
Law Offices of Howard G. Smith
BENSALEM, Pa., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith continues its investigation on behalf of Novartis AG (“Novartis” or the “Company”) (NYSE: NVS) investors concerning...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
11 sept. 2019 09h28 HE
|
Schall Law
LOS ANGELES, Sept. 11, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novartis AG...
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
04 sept. 2019 11h30 HE
|
Schall Law
LOS ANGELES, Sept. 04, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novartis AG...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
27 août 2019 12h03 HE
|
Schall Law
LOS ANGELES, Aug. 27, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Novartis AG...